PL341062A1 - Novel applications of compounds exhibiting antipsoric properties - Google Patents
Novel applications of compounds exhibiting antipsoric propertiesInfo
- Publication number
- PL341062A1 PL341062A1 PL98341062A PL34106298A PL341062A1 PL 341062 A1 PL341062 A1 PL 341062A1 PL 98341062 A PL98341062 A PL 98341062A PL 34106298 A PL34106298 A PL 34106298A PL 341062 A1 PL341062 A1 PL 341062A1
- Authority
- PL
- Poland
- Prior art keywords
- antipsoric
- properties
- compounds exhibiting
- novel applications
- novel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6374697P | 1997-10-17 | 1997-10-17 | |
PCT/US1998/021886 WO1999020280A1 (en) | 1997-10-17 | 1998-10-16 | Novel use of compounds for anti-pruritic activity |
Publications (1)
Publication Number | Publication Date |
---|---|
PL341062A1 true PL341062A1 (en) | 2001-03-26 |
Family
ID=22051225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL98341062A PL341062A1 (en) | 1997-10-17 | 1998-10-16 | Novel applications of compounds exhibiting antipsoric properties |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1030666A4 (de) |
JP (1) | JP2001520196A (de) |
KR (1) | KR20010031149A (de) |
CN (1) | CN1306426A (de) |
AR (1) | AR015966A1 (de) |
AU (1) | AU740875B2 (de) |
BR (1) | BR9814080A (de) |
CA (1) | CA2306985A1 (de) |
CO (1) | CO4810374A1 (de) |
CZ (1) | CZ20001376A3 (de) |
HU (1) | HUP0003792A3 (de) |
IL (1) | IL135581A0 (de) |
NO (1) | NO20001847L (de) |
NZ (1) | NZ503551A (de) |
PL (1) | PL341062A1 (de) |
TR (1) | TR200001040T2 (de) |
WO (1) | WO1999020280A1 (de) |
ZA (1) | ZA989450B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7250518B2 (en) | 2001-01-31 | 2007-07-31 | Pfizer Inc. | Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes |
MXPA03006885A (es) | 2001-01-31 | 2003-11-13 | Pfizer Prod Inc | Derivados de eteres utiles como agentes inhibidores de las isozimas pde4. |
BR0116852A (pt) | 2001-01-31 | 2004-02-25 | Pfizer Prod Inc | Derivados biarilados de nicotinamida úteis como inibidores de isozimas pde4 |
PL365443A1 (en) | 2001-01-31 | 2005-01-10 | Pfizer Products Inc. | Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
US20030175314A1 (en) * | 2001-11-19 | 2003-09-18 | Didriksen Erik Johannes | Pharmaceutical composition for dermal application |
WO2005007161A1 (ja) * | 2003-07-17 | 2005-01-27 | Santen Pharmaceutical Co., Ltd. | ピペリジン誘導体を有効成分とする掻痒治療剤 |
WO2005053672A1 (ja) * | 2003-12-04 | 2005-06-16 | Santen Pharmaceutical Co., Ltd. | シロミラストまたはその塩を有効成分とする掻痒治療剤 |
JP2005187458A (ja) * | 2003-12-04 | 2005-07-14 | Santen Pharmaceut Co Ltd | シロミラストまたはその塩を有効成分とする掻痒治療剤 |
WO2005077950A2 (en) * | 2004-02-14 | 2005-08-25 | Smithkline Beecham Corporation | Medicaments with hm74a receptor activity |
JP2008137892A (ja) * | 2005-03-04 | 2008-06-19 | Eisai Co Ltd | 止痒剤 |
WO2007017262A1 (en) | 2005-08-10 | 2007-02-15 | Smithkline Beecham Corporation | Xanthine derivatives as selective hm74a agonists |
TWI404709B (zh) * | 2006-02-21 | 2013-08-11 | Eisai R&D Man Co Ltd | 4- (3-benzamidophenyl) -6,7-dimethoxy-2-methylamine quinazoline derivatives |
CA2637573C (en) * | 2006-02-21 | 2013-07-02 | Eisai R&D Management Co., Ltd. | 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives |
AU2008215411B2 (en) | 2007-02-16 | 2012-11-22 | Eisai R & D Management Co., Ltd. | Crystal, amorphous form and salt of methyl N-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid |
WO2009025239A1 (ja) | 2007-08-17 | 2009-02-26 | Eisai R & D Management Co., Ltd. | 新規外用剤 |
ATE538102T1 (de) | 2007-08-17 | 2012-01-15 | Eisai R&D Man Co Ltd | Verfahren zur herstellung eines chinazolinderivats |
JP5985475B2 (ja) * | 2011-06-28 | 2016-09-06 | 田辺三菱製薬株式会社 | 新規医薬組成物 |
BR112017016065A2 (pt) | 2015-01-30 | 2018-04-03 | Shanton Pharma Co., Ltd. | prevenção ou tratamento de ácido úrico ou doença gotosa |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69132291T2 (de) * | 1990-12-21 | 2000-12-14 | Beecham Group P.L.C., Brentford | Xanthinderivate |
PT889886E (pt) * | 1996-03-26 | 2003-02-28 | Altana Pharma Ag | Novas fenantridinas substituidas na posicao 6 |
WO1997043288A1 (en) * | 1996-05-15 | 1997-11-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Novel imidazopyridines |
PT968211E (pt) * | 1997-03-07 | 2004-01-30 | Altana Pharma Ag | Derivados de tetrazoles |
CA2282845A1 (en) * | 1997-03-18 | 1998-09-24 | Basf Aktiengesellschaft | Methods and compositions for modulating responsiveness to corticosteroids |
DK0988302T3 (da) * | 1997-06-03 | 2003-06-02 | Altana Pharma Ag | Benzonaphthyridiner |
-
1998
- 1998-10-15 AR ARP980105131A patent/AR015966A1/es not_active Application Discontinuation
- 1998-10-16 HU HU0003792A patent/HUP0003792A3/hu unknown
- 1998-10-16 ZA ZA989450A patent/ZA989450B/xx unknown
- 1998-10-16 IL IL13558198A patent/IL135581A0/xx unknown
- 1998-10-16 EP EP98953608A patent/EP1030666A4/de not_active Withdrawn
- 1998-10-16 PL PL98341062A patent/PL341062A1/xx unknown
- 1998-10-16 AU AU10938/99A patent/AU740875B2/en not_active Ceased
- 1998-10-16 KR KR1020007004053A patent/KR20010031149A/ko not_active Application Discontinuation
- 1998-10-16 CN CN98810066A patent/CN1306426A/zh active Pending
- 1998-10-16 JP JP2000516677A patent/JP2001520196A/ja not_active Withdrawn
- 1998-10-16 CO CO98060225A patent/CO4810374A1/es unknown
- 1998-10-16 BR BR9814080-9A patent/BR9814080A/pt not_active IP Right Cessation
- 1998-10-16 CA CA002306985A patent/CA2306985A1/en not_active Abandoned
- 1998-10-16 CZ CZ20001376A patent/CZ20001376A3/cs unknown
- 1998-10-16 TR TR2000/01040T patent/TR200001040T2/xx unknown
- 1998-10-16 WO PCT/US1998/021886 patent/WO1999020280A1/en not_active Application Discontinuation
- 1998-10-16 NZ NZ503551A patent/NZ503551A/en unknown
-
2000
- 2000-04-10 NO NO20001847A patent/NO20001847L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999020280A1 (en) | 1999-04-29 |
HUP0003792A2 (hu) | 2001-10-28 |
NZ503551A (en) | 2002-05-31 |
AR015966A1 (es) | 2001-05-30 |
CN1306426A (zh) | 2001-08-01 |
CZ20001376A3 (cs) | 2002-06-12 |
AU740875B2 (en) | 2001-11-15 |
KR20010031149A (ko) | 2001-04-16 |
HUP0003792A3 (en) | 2001-12-28 |
EP1030666A1 (de) | 2000-08-30 |
IL135581A0 (en) | 2001-05-20 |
CO4810374A1 (es) | 1999-06-30 |
BR9814080A (pt) | 2000-09-26 |
CA2306985A1 (en) | 1999-04-29 |
ZA989450B (en) | 1999-04-19 |
TR200001040T2 (tr) | 2001-01-22 |
JP2001520196A (ja) | 2001-10-30 |
EP1030666A4 (de) | 2002-10-16 |
NO20001847D0 (no) | 2000-04-10 |
NO20001847L (no) | 2000-04-10 |
AU1093899A (en) | 1999-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL341672A1 (en) | Derivatives of benzothiazepin exhibiting hypolipidemic properties | |
ZA9810217B (en) | New composition of matter | |
PL341062A1 (en) | Novel applications of compounds exhibiting antipsoric properties | |
GB2330182B (en) | Manufacture of gaskets | |
PL331470A1 (en) | Azabicyclocarbamoyloxylic derivatives of mutiline for antibacterial applications | |
GB9404703D0 (en) | Production of difluoromethane | |
AU3057299A (en) | Sustained-release composition containing cefaclor | |
PL321546A1 (en) | Novel applications of lysozime dimers | |
PL342733A1 (en) | Biocement of improved properties | |
ZA985760B (en) | Glass composition of the silica-soda-lime-type | |
GB9722451D0 (en) | The manufacture of gaskets | |
PL328669A1 (en) | Novel applications of pyrrole derivatives | |
ZA9810718B (en) | Novel crystal modification of thiazine-indigo | |
IL130670A0 (en) | Manufacture of elongate members | |
PL325816A1 (en) | Novel derivatives of naphtylpiperazine | |
GB9318277D0 (en) | Production of difluoromethane | |
GB9706377D0 (en) | Novel compound | |
PL319263A1 (en) | Novel derivative of pyrimidinylcarbazole | |
GB9722026D0 (en) | Use of compounds | |
GB9306079D0 (en) | Production of difluoromethane | |
GB9306089D0 (en) | Production of difluoromethane | |
GB9306072D0 (en) | Production of difluoromethane | |
GB9324777D0 (en) | Production of difluoromethane | |
AUPO627197A0 (en) | Applications of LED's | |
GB9810260D0 (en) | Novel use of quinine |